This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Jun 18;73(23):3037-3038.

doi: 10.1016/j.jacc.2019.03.508.

No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril

Giuseppe Vergaro, Claudio Passino, Michele Emdin

PMID: 31196468
DOI: 10.1016/j.jacc.2019.03.508

Free article

Comment

No Aldosterone Breakthrough With the Neprilysin Inhibitor Sacubitril

Giuseppe Vergaro et al. J Am Coll Cardiol. 2019.

Free article

. 2019 Jun 18;73(23):3037-3038.

doi: 10.1016/j.jacc.2019.03.508.

Authors

Giuseppe Vergaro, Claudio Passino, Michele Emdin

PMID: 31196468
DOI: 10.1016/j.jacc.2019.03.508

No abstract available

PubMed Disclaimer

Comment on

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
Zile MR, O'Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefkowitz M, Rouleau J. Zile MR, et al. J Am Coll Cardiol. 2019 Feb 26;73(7):795-806. doi: 10.1016/j.jacc.2018.11.042. J Am Coll Cardiol. 2019. PMID: 30784673 Clinical Trial.

Similar articles

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA, Brown NJ. Hubers SA, et al. Circulation. 2016 Mar 15;133(11):1115-24. doi: 10.1161/CIRCULATIONAHA.115.018622. Circulation. 2016. PMID: 26976916 Free PMC article. Review.
Neprilysin inhibition with sacubitril/valsartan in the treatment of heart failure: mortality bang for your buck.
Ansara AJ, Kolanczyk DM, Koehler JM. Ansara AJ, et al. J Clin Pharm Ther. 2016 Apr;41(2):119-27. doi: 10.1111/jcpt.12363. Epub 2016 Mar 18. J Clin Pharm Ther. 2016. PMID: 26992459 Review.
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP; PARAGON-HF Investigators and Committees. Solomon SD, et al. N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475794 Clinical Trial.
[ANMCO position paper on sacubitril/valsartan in the management of patients with heart failure].
Di Tano G, Di Lenarda A, Gabrielli D, Aspromonte N, De Maria R, Frigerio M, Iacoviello M, Mortara A, Murrone A, Nardi F, Oliva F, Pontremoli R, Scherillo M, Senni M, Urbinati S, Gulizia MM. Di Tano G, et al. G Ital Cardiol (Rome). 2018 Oct;19(10):568-590. doi: 10.1714/2978.29843. G Ital Cardiol (Rome). 2018. PMID: 30281045 Italian.
Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure.
Marques da Silva P, Aguiar C. Marques da Silva P, et al. Rev Port Cardiol. 2017 Sep;36(9):655-668. doi: 10.1016/j.repc.2016.11.013. Epub 2017 Aug 23. Rev Port Cardiol. 2017. PMID: 28844335 Review. English, Portuguese.

See all similar articles

Cited by

Molecular and Epigenetic Control of Aldosterone Synthase, CYP11B2 and 11-Hydroxylase, CYP11B1.
Takeda Y, Demura M, Kometani M, Karashima S, Yoneda T, Takeda Y. Takeda Y, et al. Int J Mol Sci. 2023 Mar 17;24(6):5782. doi: 10.3390/ijms24065782. Int J Mol Sci. 2023. PMID: 36982850 Free PMC article. Review.
DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases.
Takeda Y, Demura M, Yoneda T, Takeda Y. Takeda Y, et al. Int J Mol Sci. 2021 Apr 27;22(9):4587. doi: 10.3390/ijms22094587. Int J Mol Sci. 2021. PMID: 33925539 Free PMC article. Review.
Effects of sacubitril-valsartan on central and obstructive apneas in heart failure patients with reduced ejection fraction.
Wang Y, Branco RF, Salanitro M, Penzel T, Schöbel C. Wang Y, et al. Sleep Breath. 2023 Mar;27(1):283-289. doi: 10.1007/s11325-022-02623-0. Epub 2022 Apr 29. Sleep Breath. 2023. PMID: 35486312 Free PMC article.
Renin profiling predicts neurohormonal response to sacubitril/valsartan.
Vergaro G, Sciarrone P, Prontera C, Masotti S, Musetti V, Valleggi A, Giannoni A, Senni M, Emdin M, Passino C. Vergaro G, et al. ESC Heart Fail. 2021 Feb;8(1):719-724. doi: 10.1002/ehf2.13085. Epub 2020 Nov 20. ESC Heart Fail. 2021. PMID: 33216460 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information